Overview
Celltrion Poland operates in the biopharmaceutical industry and offers a portfolio of biopharmaceutical products. Its activities include research and development, manufacturing, and distribution of products available worldwide.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2023, 2 days late).
- 2025not filed
- 202414/07/2025
- 202317/07/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Offer
- Infliximab biosimilar
- Rituximab biosimilar
- Trastuzumab biosimilar
- Adalimumab biosimilar
- Bevacizumab biosimilar
- Ustekinumab biosimilar
- Omalizumab biosimilar
- Aflibercept biosimilar
Website technology
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Manner of representation
Each member of the management board of the company has the right to represent the company individually.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Celltrion Healthcare Hungary Kft | 9,699 | $261,993.52 | 99.9897% |
Others | 1 | $27.01 | 0.0103% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-11-25.
95 1030 1508 0000 0008 2348 5000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Biocantosp. z o.o. | $1,951,967.77 | biocanto.pl | ||
| Chem-Pro Polandsp. z o.o. | $1,780,296.92 | chempropoland.com | ||
| Biobest Polskasp. z o.o. | $1,545,994.85 | biobestpolska.com.pl | ||
| Atradis Polskasp. z o.o. | $1,284,064.17 | atradis.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Tabfarmsp. z o.o. | $1,120,167.96 | tabfarm.pl | ||
| Tribotec Polskasp. z o.o. | $1,095,836.59 | tribotec.pl | ||
| Ntradesp. z o.o. | $1,002,487.20 | ntrade.com.pl | ||
| PharmenaS.A. | $541,436.46 | pharmena.eu |
FAQ
Last updated: 2026-10-07